Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Mevion pulls plug on $69m IPO
Mevion Medical withdrew plans for the $69 million initial public offering it registered for last fall, according to an SEC filing published last week.
The company produces single-room-proton therapy systems, a smaller, cheaper radiation therapy system for targeting cancerous tumors. Read more
2. Boston Scientific closes $1.6B Endo urology portfolio buy
Boston Scientific said it closed its $1.6 billion acquisition of the Endo Health Solutions owned American Medical Systems urology portfolio, including its men’s health and prostate health businesses.
The deal consists of a $1.6 billion up-front payment and a potential $50 million milestone payment based on 2016 sales, according to the companies. Read more
1. Boston Scientific inks deal with Preventice
Boston Scientific said it inked a sales and marketing deal with cardio-focused remote patient care company Preventice Solutions.
The new deal will position medical device giant Boston Scientific as Preventice’s exclusive sales and marketing representative for its cardiology-related diagnostic and monitoring offerings, the companies said. Read more
